Amedeo Smart

Free Medical Literature Service

 

Amedeo

Colorectal Neoplasms
  Free Subscription

Articles published in
Br J Surg
    April 2026
  1. WULLAERT L, van Leeuwen L, de Weerd V, Van M, et al
    Presurgical levels of circulating tumour DNA in patients with resectable chemotherapy-naive colorectal liver metastases: association with multiorgan recurrence and survival in the MIRACLE cohort.
    Br J Surg. 2026;113:znaf295.
    >> Share

  2. TEMPERLEY HC, Coalter M, Creavin B, Jordan P, et al
    Evaluating the impact of GLP-1 receptor agonists in combination with total neoadjuvant therapy for locally advanced rectal cancer.
    Br J Surg. 2026;113:znag029.
    >> Share

    March 2026
  3. IMAM I, Nilsson PJ, Khan T, Angenete E, et al
    Locoregional and systemic control after total neoadjuvant therapy with short-course radiotherapy for locally advanced rectal cancer: long-term outcomes from the LARCT-US study.
    Br J Surg. 2026;113:znag014.
    >> Share

  4. CAVAZZONI E, Desantis M, Vivaldi C, Schafer H, et al
    Anal high-grade squamous intraepithelial lesions: identification, classification, and management.
    Br J Surg. 2026;113:znag006.
    >> Share

    February 2026
  5. TAN JH, Yan IWJ, Chang JHE, Khoo MSQ, et al
    Non-operative management of mismatch repair-deficient (dMMR) / micro satellite instability-high (MSI-H) colorectal cancer treated with immunotherapy: systematic review and meta-analysis.
    Br J Surg. 2026;113:znaf284.
    >> Share

    December 2025
  6. RUBIO-ALARCON C, Georgiadis A, Franken IA, Wang H, et al
    Circulating tumour DNA in patients with stage III colon cancer: multicentre prospective PROVENC3 study.
    Br J Surg. 2025;113:znaf281.
    >> Share

    November 2025

  7. Multiple primary tumours in early-onset colorectal cancer: deciphering the risk.
    Br J Surg. 2025;112:znaf244.
    >> Share

    September 2025
  8. TAIEB J, Karoui M
    Challenges of decision-making after treatment with immunotherapy in metastatic deficient DNA mismatch repair/microsatellite unstable colorectal cancer.
    Br J Surg. 2025;112:znaf178.
    >> Share

  9. REESE T, Bjork D, Longva AMH, Kiim KS, et al
    Oncological safety of portal vein embolization without prior tumour clearance in the future liver remnant followed by one-stage hepatectomy for bilateral colorectal liver metastases.
    Br J Surg. 2025;112:znaf198.
    >> Share


  10. Covered versus uncovered endoluminal stenting in the acute management of obstructing colorectal cancer in the palliative setting: randomized clinical trial (CReST2).
    Br J Surg. 2025;112:znaf117.
    >> Share

  11. HELLIWELL JA, Chilton CH, Young C, Clark EV, et al
    Perioperative changes in the microbiome during rectal cancer surgery: exploratory analysis of the National Institute for Health and Care Research (NIHR) IntAct trial.
    Br J Surg. 2025;112:znaf199.
    >> Share

  12. PRATA I, Tanaka MD, Glimelius B, Nagtegaal ID, et al
    Factors influencing locoregional recurrence rates in locally advanced rectal cancer after total neoadjuvant treatment versus chemoradiotherapy in the RAPIDO trial.
    Br J Surg. 2025;112:znaf190.
    >> Share

    August 2025
  13. VU JK, Brown KGM, Solomon MJ, Ng KS, et al
    Patterns and outcomes of disease recurrence after pelvic exenteration for locally recurrent rectal cancer.
    Br J Surg. 2025;112:znaf154.
    >> Share

    May 2025
  14. FLETCHER JA, Corr A, Drami I, Taylor C, et al
    Enhancing decision-making and patient comprehension in complex rectal cancer surgery through personalized three-dimensional imaging: randomized feasibility study.
    Br J Surg. 2025;112:znaf116.
    >> Share


  15. Correction to: Tumour deposit count is an independent prognostic factor in colorectal cancer-a population-based cohort study.
    Br J Surg. 2025;112:znaf135.
    >> Share

    March 2025
  16. GEUBELS BM, Grotenhuis BA, van den Esschert AJ, Lambregts DMJ, et al
    National implementation of Watch-and-Wait in patients with rectal cancer.
    Br J Surg. 2025;112:znaf040.
    >> Share

  17. MOOSAVI SH, Kryeziu K, Eilertsen IA, Nunes L, et al
    Molecular prognostic factors for liver transplantation of unresectable metastatic colorectal cancer.
    Br J Surg. 2025;112:znaf072.
    >> Share


  18. Metachronous colorectal cancer risks after extended or segmental resection in MLH1, MSH2, and MSH6 Lynch syndrome: multicentre study from the Prospective Lynch Syndrome Database.
    Br J Surg. 2025;112:znaf061.
    >> Share

  19. HAMM JJM, van den Berg R, Andrinopoulou ER, Zwanenburg ES, et al
    Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colon cancer at high risk of peritoneal metastases: individual patient data meta-analysis.
    Br J Surg. 2025;112:znaf076.
    >> Share

  20. SELIGMANN JF
    Colorectal cancer staging-time for a re-think on TNM?
    Br J Surg. 2025;112:znaf047.
    >> Share

  21. PANG K, Liu X, Yao H, Lin G, et al
    Impact of PD1 blockade added to neoadjuvant chemoradiotherapy on rectal cancer surgery: post-hoc analysis of the randomized POLARSTAR trial.
    Br J Surg. 2025;112:znaf057.
    >> Share

    December 2024
  22. LUNDSTROM S, Agger E, Lydrup ML, Jorgren F, et al
    Tumour deposit count is an independent prognostic factor in colorectal cancer-a population-based cohort study.
    Br J Surg. 2024;112:znae309.
    >> Share

    October 2024
  23. CAI ZH, Guo YC, Ye K, Xiao Y, et al
    Infrapyloric and gastroepiploic lymph node metastasis in right transverse colon cancer (InCLART study): multicentre, prospective, observational study.
    Br J Surg. 2024;111:znae272.
    >> Share

    September 2024
  24. WENZELBERG CL, Rogmark P, Ekberg O, Petersson U, et al
    Reinforced tension-line suture after laparotomy: early results of the Rein4CeTo1 randomized clinical trial.
    Br J Surg. 2024;111:znae265.
    >> Share

    August 2024
  25. PAOLUCCI I, Albuquerque Marques Silva J, Lin YM, Laimer G, et al
    Identification of A0 minimum ablative margins for colorectal liver metastases: multicentre, retrospective study using deformable CT registration and artificial intelligence-based autosegmentation.
    Br J Surg. 2024;111:znae165.
    >> Share

  26. SOREIDE K, Kok NFM
    Curative-intent ablation margins (A0) for colorectal liver metastasis: more burning questions.
    Br J Surg. 2024;111:znae184.
    >> Share

  27. ZUKAUSKAITE K, Horvath A, Gricius Z, Kvietkauskas M, et al
    Impact of mechanical bowel preparation on the gut microbiome of patients undergoing left-sided colorectal cancer surgery: randomized clinical trial.
    Br J Surg. 2024;111:znae213.
    >> Share

  28. VALDMAN A, Marsk R, Karimi M, Asklid D, et al
    Surgical outcomes following total neoadjuvant therapy in rectal cancer with short-course radiotherapy using protons or photons: initial safety data from the PRORECT randomized trial.
    Br J Surg. 2024;111:znae241.
    >> Share

  29. WILLIAMS H, Yuval JB, Verheij FS, Miranda J, et al
    Baseline MRI predictors of successful organ preservation in the Organ Preservation in Rectal Adenocarcinoma (OPRA) trial.
    Br J Surg. 2024;111:znae246.
    >> Share

  30. OZCAN C, Colak T, Turkmenoglu O, Berkesoglu M, et al
    Impact of small-bite (5 mm) fascial closure on the incidence of incisional hernia following open colorectal cancer surgery: randomized clinical trial.
    Br J Surg. 2024;111:znae189.
    >> Share

  31. BOZKURT E, Sijberden JP, Langella S, Cipriani F, et al
    Laparoscopic versus open right hepatectomy for colorectal liver metastases after portal vein embolization: international multicentre study.
    Br J Surg. 2024;111:znae181.
    >> Share

  32. PEDRAZZANI C, Turri G, Ostuzzi G, Barbui C, et al
    Comment on: Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials.
    Br J Surg. 2024;111:znae209.
    >> Share

  33. DONNELLY M, Ryan OK, Ryan EJ, Winter DC, et al
    Author response to: Comment on: Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials.
    Br J Surg. 2024;111:znae211.
    >> Share

    July 2024
  34. MARGONIS GA, Wang JJ, Boerner T, Moretto R, et al
    Hepatectomy versus systemic therapy for liver-limited BRAF V600E-mutated colorectal liver metastases: multicentre retrospective study.
    Br J Surg. 2024;111:znae176.
    >> Share

  35. JOYCE A, Drake TM, Hampson C, Monaghan A, et al
    Comment on: Effect of centre volume on pathological outcomes and postoperative complications after surgery for colorectal cancer: results of a multicentre national study.
    Br J Surg. 2024;111:znae194.
    >> Share

  36. ROTTOLI M, Spinelli A, Pellino G, Gori A, et al
    Author response to: Comment on: Effect of centre volume on pathological outcomes and postoperative complications after surgery for colorectal cancer: results of a multicentre national study.
    Br J Surg. 2024;111:znae193.
    >> Share

  37. GUAN X, Zhao X, Jiao S, Hao R, et al
    Circulating immune cell profile in patients with colorectal cancer.
    Br J Surg. 2024;111:znae186.
    >> Share

    June 2024
  38. BAO QR, Ferrari S, Capelli G, Chiloiro G, et al
    Oncological outcomes of patients not undergoing Total Mesorectal Excision after local excision: rethinking surgical indications.
    Br J Surg. 2024;111:znae144.
    >> Share

    May 2024
  39. ZAFFARONI G, Mannucci A, Koskenvuo L, de Lacy B, et al
    Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint EH
    Br J Surg. 2024;111:znae070.
    >> Share

  40. OLTHOF K, Smit J, Fusaglia M, Kok N, et al
    A surgical navigation system to aid the ablation of vanished colorectal liver metastases.
    Br J Surg. 2024;111:znae110.
    >> Share

  41. GABRIELE R, Campagnol M, Iannone I, Sapienza P, et al
    Faecal occult blood and sigmoidoscopy data from the Italian national screening programme.
    Br J Surg. 2024;111:znae131.
    >> Share

    April 2024
  42. KRUL MF, Kok NFM, Osmani H, Buisman FE, et al
    Hepatic arterial infusion pump chemotherapy combined with systemic chemotherapy for borderline resectable and unresectable colorectal liver metastases: phase II feasibility study.
    Br J Surg. 2024;111:znae089.
    >> Share

    March 2024
  43. CUK P, Tiskus M, Moller S, Lambertsen KL, et al
    Surgical stress response in robot-assisted versus laparoscopic surgery for colon cancer (SIRIRALS): randomized clinical trial.
    Br J Surg. 2024;111:znae049.
    >> Share

  44. GLYNNE-JONES R, Harrison M
    Colorectal cancer para-aortic lymph node metastases: surgery should not be considered.
    Br J Surg. 2024;111:znad443.
    >> Share

  45. PEACOCK O
    Colorectal cancer para-aortic lymph node metastases-surgery should be considered.
    Br J Surg. 2024;111:znad445.
    >> Share

  46. PEREA J, Garcia JL, Corchete LA, Marti M, et al
    Chromosomal breaks: another differential gap between early-onset and late-onset colorectal cancers.
    Br J Surg. 2024;111:znae041.
    >> Share

  47. MARTIN-CULLELL B, Virgili AC, Riera P, Fumagalli C, et al
    Histopathological, Clinical, And Molecular (HICAM) score for patients with colorectal liver metastases.
    Br J Surg. 2024;111:znae016.
    >> Share

    October 2023
  48. SPOLVERATO G, Fassan M, Scarpa M, Stepanyan A, et al
    IMMUNOREACT 6: weak immune surveillance characterizes early-onset rectal cancer.
    Br J Surg. 2023;110:1490-1501.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016